These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2744079)

  • 1. [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B.
    Cesura AM; Galva MD; Imhof R; Kyburz E; Picotti GB; Da Prada M
    Eur J Pharmacol; 1989 Mar; 162(3):457-65. PubMed ID: 2744079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes.
    Cesura AM; Imhof R; Takacs B; Galva MD; Picotti GB; Da Prada M
    J Neurochem; 1988 Apr; 50(4):1037-43. PubMed ID: 3126263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
    Cesura AM; Bös M; Galva MD; Imhof R; Da Prada M
    Mol Pharmacol; 1990 Mar; 37(3):358-66. PubMed ID: 2314388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of [3H]Ro 16-6491, a reversible inhibitor of monoamine oxidase type B, to human brain mitochondria and platelet membranes.
    Cesura AM; Galva MD; Imhof R; Da Prada M
    J Neurochem; 1987 Jan; 48(1):170-6. PubMed ID: 3794699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase inhibition by moclobemide and 2-amino-ethyl carboxamide derivatives: mode of action and kinetic characteristics.
    Cesura AM; Muggli-Maniglio D; Lang G; Imhof R; Da Prada M
    J Neural Transm Suppl; 1990; 32():165-70. PubMed ID: 2089085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the novel inhibitors of MAO-B Ro 19-6327 and Ro 16-6491 with the active site of the enzyme.
    Cesura AM; Imhof R; Galva MD; Kettler R; Da Prada M
    Pharmacol Res Commun; 1988 Dec; 20 Suppl 4():51-61. PubMed ID: 3244727
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.
    Bench CJ; Price GW; Lammertsma AA; Cremer JC; Luthra SK; Turton D; Dolan RJ; Kettler R; Dingemanse J; Da Prada M
    Eur J Clin Pharmacol; 1991; 40(2):169-73. PubMed ID: 1906004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAO-B inhibition in rabbit tissues and in human platelets by Ro 19-6327 shows similar time-course.
    Kettler R; Cesura AM; Dingemanse J; Da Prada M
    J Neural Transm Suppl; 1990; 32():211-4. PubMed ID: 2089093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
    Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL
    J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    Da Prada M; Kettler R; Keller HH; Burkard WP; Muggli-Maniglio D; Haefely WE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):400-14. PubMed ID: 2783611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
    Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.
    Saura J; Kettler R; Da Prada M; Richards JG
    J Neurosci; 1992 May; 12(5):1977-99. PubMed ID: 1578281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.
    Henriot S; Kuhn C; Kettler R; Da Prada M
    J Neural Transm Suppl; 1994; 41():321-5. PubMed ID: 7931245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of [3H]quinpirole binding at striatal D2 dopamine receptors by a monoamine oxidaseA-like site: evidence from radioligand binding studies and D2 receptor- and MAO(A)-deficient mice.
    Levant B; Morgan KA; Ahlgren-Beckendorf JA; Grandy DK; Chen K; Shih JC; Seif I
    Life Sci; 2001 Nov; 70(2):229-41. PubMed ID: 11787947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioautographic evidence that the GABAA receptor antagonist SR 95531 is a substrate inhibitor of MAO-A in the rat and human locus coeruleus.
    Luque JM; Erat R; Kettler R; Cesura A; Da Prada M; Richards JG
    Eur J Neurosci; 1994 Jun; 6(6):1038-49. PubMed ID: 7952273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.